Headquartered in New York, NY Fiscal year ends December NYSE: TDOC teladochealth.com
Teladoc Health is a global virtual care company that delivers and orchestrates care across patients, care providers, platforms, and partners. The company operates through two segments: Integrated Care and BetterHelp. The Integrated Care segment provides a suite of virtual medical services including general medical, expert medical services, specialty medical, chronic condition management, mental health, and enabling technologies and enterprise telehealth solutions for hospitals and health systems, serving approximately 100 million U.S. members through relationships with health plans, employers, providers, and health systems. The BetterHelp segment offers virtual therapy, psychiatry, and wellness services marketed primarily on a direct-to-consumer basis, serving both cash-pay users and those utilizing insurance coverage. The company generates revenue through access fees from enterprise clients and visit-based arrangements, as well as direct consumer subscriptions and insurance-reimbursed sessions. Teladoc Health serves both U.S. and international markets, with international revenue comprising a growing share of total revenue. Updated
Hims & Hers (NYSE:HIMS) is dominating headlines this week because the GLP-1 darling just delivered one of the ugliest quarters in the telehealth sector’s short history, and bargain hunters are circling the…
Teladoc Health (NYSE:TDOC) has staged a notable recovery off its lows, but the stock remains under significant pressure from its longer-term trajectory. Shares are up 1.37% over the past week and have…
Joel South Three health-technology names are drawing fresh analyst attention this week as strategic partnerships and business pivots reframe the risk-reward calculus for each. Hims & Hers Health (NYSE:HIMS) received two separate upgrades after…
Stock markets got a bit of a shock on Friday after a University of Michigan survey showed consumers are anticipating inflation to rise in 2025, potentially depressing consumer spending and dissuading the…
2015 was one of the worst years for IPOs in the past decade. Only 2016 and 2022 were worse. But there were some big winners.
Friday's top analyst upgrades and downgrades included Advanced Micro Devices, Asana, Etsy, Exact Sciences, Guardant Health, Hilton Worldwide, Meta Platforms, MongoDB, Salesforce, ServiceNow, Sysco and Teladoc Health.
Counseling therapy service BetterHelp, which is owned by Teladoc, was fined a relatively light $7.8 million for revealing confidential customer data to websites the company advertised with.
Paul Ausick Friday's top analyst upgrades and downgrades included AppLovin, CarMax, Cinemark, Diamondback Energy, Enovix, Etsy, Graphic Packaging, Home Depot, Intel, Lucid, Nvidia, Teladoc Health, Walgreen Boots Alliance and Workday.
Monday's top analyst upgrades and downgrades included AT&T, ADM, Chevron, FedEx, Intel, Meta, Qualcomm and more.
Thursday's top analyst upgrades and downgrades included Apple, ChargePoint, Chimerix, Cincinnati Financial, Coinbase Global, DocuSign, EQT, Fastenal, iQIYI, Petco Health & Wellness, Stem and United Parcel Service.
Wednesday's additional top analyst upgrades and downgrades were on DraftKings, Rockwell Automation, Sandstorm Gold, Stanley Black & Decker, Take-Two Interactive Software, Teladoc Health, Yum! Brands and more.
Monday’s top analyst upgrades and downgrades included Archer Daniels Midland, Crowdstrike, GoodRx, Illumina, Oracle, Payoneer Global, Palo Alto Networks, Playa Hotels, Rivian Automotive, Salesforce, Teladoc, Toast and Warby Parker.
Tuesday's additional top analyst upgrades and downgrades included Cracker Barrel, Farfetch, Intel, Kodiak Sciences, Pinterest, Snowflake, Teladoc and more.
Canaccord Genuity recently issued a few calls across multiple industries implying serious upside for each stock.
Thursday's additional top analyst upgrades and downgrades included Best Buy, Kraft Heinz, Qualcomm, Stitch Fix, Shopify, Teladoc, Verizon, and more.
Teladoc Health is a global virtual care company that delivers and orchestrates care across patients, care providers, platforms, and partners. The company operates through two segments: Integrated Care and BetterHelp.
The Wall Street consensus 12-month price target for TDOC is $7.59.
